Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

Company Overview - Nevro (NVRO) shares have increased by approximately 0.9% since the last earnings report, outperforming the S&P 500 [1] - The most recent earnings report is essential for understanding the key drivers of the company's performance [1] Earnings Estimates - Estimates for Nevro have trended upward over the past month, indicating positive sentiment among analysts [2][4] - The current Zacks Rank for Nevro is 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] VGM Scores - Nevro has a Growth Score of B, a Momentum Score of F, and a Value Score of C, resulting in an aggregate VGM Score of C, placing it in the middle 20% for investment strategies [3] Industry Performance - Nevro operates within the Zacks Medical - Instruments industry, where Fresenius (FMS) has seen a 4.3% increase in share price over the past month [5] - Fresenius reported revenues of $5.42 billion for the last quarter, reflecting a year-over-year growth of 1%, with an EPS of $0.48 compared to $0.47 a year ago [5] - Fresenius is projected to earn $0.45 per share for the current quarter, representing a year-over-year increase of 25%, with a Zacks Consensus Estimate revision of 3.5% over the last 30 days [6] - Fresenius holds a Zacks Rank of 1 (Strong Buy) and has a VGM Score of B, indicating strong performance expectations [6]